vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and Service Properties Trust (SVC). Click either name above to swap in a different company.

Service Properties Trust is the larger business by last-quarter revenue ($296.5M vs $209.8M, roughly 1.4× MYRIAD GENETICS INC). On growth, MYRIAD GENETICS INC posted the faster year-over-year revenue change (-0.4% vs -17.0%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -6.1%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...

MYGN vs SVC — Head-to-Head

Bigger by revenue
SVC
SVC
1.4× larger
SVC
$296.5M
$209.8M
MYGN
Growing faster (revenue YoY)
MYGN
MYGN
+16.6% gap
MYGN
-0.4%
-17.0%
SVC
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-6.1%
SVC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYGN
MYGN
SVC
SVC
Revenue
$209.8M
$296.5M
Net Profit
$-782.0K
Gross Margin
70.0%
Operating Margin
-2.7%
-3.9%
Net Margin
-0.3%
Revenue YoY
-0.4%
-17.0%
Net Profit YoY
99.0%
EPS (diluted)
$-0.09
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
SVC
SVC
Q4 25
$209.8M
$296.5M
Q3 25
$205.7M
$377.6M
Q2 25
$213.1M
$404.4M
Q1 25
$195.9M
$335.0M
Q4 24
$210.6M
$357.0M
Q3 24
$213.3M
$390.9M
Q2 24
$211.5M
$412.5M
Q1 24
$202.2M
$336.2M
Net Profit
MYGN
MYGN
SVC
SVC
Q4 25
$-782.0K
Q3 25
$-27.4M
$-46.9M
Q2 25
$-330.5M
$-38.2M
Q1 25
$-100.0K
$-116.4M
Q4 24
$-76.4M
Q3 24
$-22.1M
$-46.9M
Q2 24
$-36.7M
$-73.8M
Q1 24
$-26.0M
$-78.4M
Gross Margin
MYGN
MYGN
SVC
SVC
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Q1 24
68.1%
Operating Margin
MYGN
MYGN
SVC
SVC
Q4 25
-2.7%
-3.9%
Q3 25
-11.3%
-12.8%
Q2 25
-154.5%
-9.2%
Q1 25
-14.8%
-33.3%
Q4 24
-18.6%
-19.4%
Q3 24
-9.4%
-12.8%
Q2 24
-17.3%
-17.1%
Q1 24
-13.8%
-21.4%
Net Margin
MYGN
MYGN
SVC
SVC
Q4 25
-0.3%
Q3 25
-13.3%
-12.4%
Q2 25
-155.1%
-9.4%
Q1 25
-0.1%
-34.8%
Q4 24
-21.4%
Q3 24
-10.4%
-12.0%
Q2 24
-17.4%
-17.9%
Q1 24
-12.9%
-23.3%
EPS (diluted)
MYGN
MYGN
SVC
SVC
Q4 25
$-0.09
$-0.01
Q3 25
$-0.29
$-0.28
Q2 25
$-3.57
$-0.23
Q1 25
$0.00
$-0.70
Q4 24
$-0.47
$-0.46
Q3 24
$-0.24
$-0.28
Q2 24
$-0.41
$-0.45
Q1 24
$-0.29
$-0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
SVC
SVC
Cash + ST InvestmentsLiquidity on hand
$149.6M
$346.8M
Total DebtLower is stronger
$119.9M
$5.5B
Stockholders' EquityBook value
$368.0M
$646.1M
Total Assets
$706.6M
$6.5B
Debt / EquityLower = less leverage
0.33×
8.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
SVC
SVC
Q4 25
$149.6M
$346.8M
Q3 25
$145.4M
$417.4M
Q2 25
$74.4M
$63.2M
Q1 25
$91.8M
$80.1M
Q4 24
$102.4M
$143.5M
Q3 24
$99.9M
$48.6M
Q2 24
$97.3M
$14.6M
Q1 24
$104.3M
$71.3M
Total Debt
MYGN
MYGN
SVC
SVC
Q4 25
$119.9M
$5.5B
Q3 25
$119.5M
Q2 25
Q1 25
Q4 24
$5.8B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MYGN
MYGN
SVC
SVC
Q4 25
$368.0M
$646.1M
Q3 25
$372.8M
$647.9M
Q2 25
$388.1M
$695.9M
Q1 25
$704.9M
$734.6M
Q4 24
$701.1M
$851.9M
Q3 24
$731.7M
$929.0M
Q2 24
$740.5M
$1.0B
Q1 24
$760.0M
$1.1B
Total Assets
MYGN
MYGN
SVC
SVC
Q4 25
$706.6M
$6.5B
Q3 25
$728.1M
$7.0B
Q2 25
$677.3M
$6.9B
Q1 25
$1.0B
$7.0B
Q4 24
$1.0B
$7.1B
Q3 24
$1.1B
$7.1B
Q2 24
$1.1B
$7.1B
Q1 24
$1.1B
$7.2B
Debt / Equity
MYGN
MYGN
SVC
SVC
Q4 25
0.33×
8.52×
Q3 25
0.32×
Q2 25
Q1 25
Q4 24
6.85×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
SVC
SVC
Operating Cash FlowLast quarter
$10.6M
$-18.5M
Free Cash FlowOCF − Capex
$-95.2M
FCF MarginFCF / Revenue
-32.1%
Capex IntensityCapex / Revenue
25.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-107.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
SVC
SVC
Q4 25
$10.6M
$-18.5M
Q3 25
$21.1M
$98.1M
Q2 25
$-13.6M
$-7.0K
Q1 25
$-16.3M
$38.2M
Q4 24
$6.6M
$-9.7M
Q3 24
$700.0K
$106.2M
Q2 24
$2.6M
$43.8M
Q1 24
$-18.6M
$-926.0K
Free Cash Flow
MYGN
MYGN
SVC
SVC
Q4 25
$-95.2M
Q3 25
$57.9M
Q2 25
$-46.6M
Q1 25
$-23.2M
Q4 24
$-88.9M
Q3 24
$24.1M
Q2 24
$-22.3M
Q1 24
$-77.2M
FCF Margin
MYGN
MYGN
SVC
SVC
Q4 25
-32.1%
Q3 25
15.3%
Q2 25
-11.5%
Q1 25
-6.9%
Q4 24
-24.9%
Q3 24
6.2%
Q2 24
-5.4%
Q1 24
-23.0%
Capex Intensity
MYGN
MYGN
SVC
SVC
Q4 25
25.9%
Q3 25
10.6%
Q2 25
11.5%
Q1 25
18.3%
Q4 24
22.2%
Q3 24
21.0%
Q2 24
16.0%
Q1 24
22.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons